Search This Blog

Monday, September 10, 2018

Aridis Pharmaceuticals initiated at Northland


Aridis Pharmaceuticals initiated with an Outperform at Northland. Northland analyst Carl Byrns initiated Aridis Pharmaceuticals with an Outperform and $40 price target.
https://thefly.com/landingPageNews.php?id=2787949

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.